Navigation Links
Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
Date:9/14/2010

gest pharmaceutical markets in the world including endometriosis, anxiety, depression, pain, diabetes, irritable bowel syndrome, insomnia, and other neurological and endocrine related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's CRF program and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's CRF program include, but are not limited to, risk that GSK may terminate its development of GSK561679 and/or its collaboration with the Company;  risk that the ongoing GSK561679 clinical trials will fail to demonstrate that GSK561679 is safe and effective; risk that the Company's CRF program backup product candidates will not prove suitable for clinical development; risk that the Company will be unable to raise additional funding required to complete development of its CRF program product candidates; risk associated with the Company's dependence on corporate partners for future clinical development, commercial manufacturing and marketing and sales activities; uncertainties relating to patent protection and intellectual property rights of third parties; risks and uncertainties relating to competitive products and technological changes that may limit demand for the Company's CRF program products; and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2009 and reports on Form 10-Q for the quarter ende
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
2. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
3. Neurocrine Biosciences to Present at the Deutsche Bank 35th Annual Health Care Conference
4. Neurocrine Biosciences to Present at the 30th Annual Cowen & Co. Health Care Conference
5. Neurocrine Biosciences, Inc. Prices Common Stock Offering
6. Neurocrine Announces Proposed Public Offering of Common Stock
7. Neurocrine Advances VMAT2 Inhibitor Program
8. Neurocrine Biosciences to Present at the 21st Annual Piper Jaffray Health Care Conference
9. Neurocrine Biosciences Reports Third Quarter 2009 Results
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2009 Financial Results
11. Neurocrine Biosciences Presents Elagolix Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 ... announced today that the company,s board of directors approved a ... June 30. Accordingly, DelMar will file a Transition Form 10K ... Bacha , president and CEO of DelMar stated, "The change ... our goal of obtaining a senior exchange listing for our ...
(Date:7/24/2014)... N.C. , July 24, 2014 ... has signed an Agreement with Kineticos, a ... consulting company. Kineticos will support LSI Medience in ... sepsis management, to demonstrate utility in clinical trials. ... shown potential utility in diagnosis of sepsis, prognosis ...
(Date:7/24/2014)... , July 24, 2014 Talyst, a market ... 2014 National Association of State Veterans Homes (NASVH) Summer ... The goal of the NASVH is to ensure that ... services, long term health care and respect which they ... With the InSite® Remote Dispensing System, Talyst can ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment 2Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2
... 1, 2011 Reportlinker.com announces that a ... its catalogue: Dry Powder ... http://www.reportlinker.com/p0581176/Dry-Powder-Inhalation-Devices-Drugs-Therapeutics-Markets-and-Forecasts ... formulation and inhalation device design are creating ...
... 1, 2011 Reportlinker.com announces that a ... its catalogue: Insulin- Global ... This package contains 63 insulin market ... Bulgaria, Czech Republic,Denmark, Estonia, Finland, France, Germany, ...
Cached Medicine Technology:Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts 2Dry Powder Inhalation: Devices, Drugs, Therapeutics, Markets and Forecasts 3Insulin- Global 2
(Date:7/24/2014)... Doheny HealthDay Reporter THURSDAY, ... often don,t view their kids as unhealthy or recognize the ... new study. The children of the families surveyed for ... Hasbro Children,s Hospital in Providence, R.I. "A third categorized ... researcher Dr. Kyung Rhee, now an assistant professor of pediatrics ...
(Date:7/24/2014)... researchers may have found a way to delay or ... of neurons with the anti-aging protein Klotho can prevent ... protein and glutamate. These findings currently appear in the ... disease is the most frequent age-related dementia affecting 5.4 ... and older and more than 40 percent of people ...
(Date:7/24/2014)... SHAWNEE, Kan. (PRWEB) July 24, 2014 ... announces that it has achieved certification for ... as tested and verified by the DoD Information ... Acuo Vendor Neutral Archive, identified within the DoD ... the Authority to Operate designation from the U.S. ...
(Date:7/24/2014)... equally positive outcomes experience paradoxical feelings of pleasure ... regions of the brain, according to research led ... the Princeton Neuroscience Institute at Princeton University. ... desirability of more than 300 products using an ... paired products with different or similar values and ...
(Date:7/24/2014)... 2014 Horizon BCBSNJ’s second annual “Back ... family a rent-free week in a beautiful Lavallette shore ... Don’t miss your chance to win a week’s vacation ... all New Jersey residents, 25 or older.* Residents can ... http://www.facebook.com/HorizonBCBSNJ . , “A family vacation at the ...
Breaking Medicine News(10 mins):Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 2Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 3Health News:Perceptive Software Achieves DIACAP Certification for Vendor Neutral Archive Solution to Support U.S. Department of Defense Integrated Clinical Systems Program 4Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:(Beach) Sands of Time Running out to Enter Horizon Blue Cross Blue Shield of New Jersey’s 2014 “Back to the Boardwalk” Sweepstakes 2
... healthcare grade televisions and on-demand patient and staff interactive education ... education and entertainment system into Timpanogos Regional Hospital in Orem, ... ... Raleigh, NC (Vocus) May 20, 2009 -- TeleHealth Services ...
... and nerve damage , , WEDNESDAY, May 20 (HealthDay News) -- ... their blood glucose levels at a normal, low level. ... when it comes to avoiding the complications of the disease, ... Diabetes is a disease in which the body does not ...
... Minn., May 20 Orasi Medical, Inc. announced today ... financing round.The company will use this capital to expand ... the pharmaceutical and clinical markets. Pharmaceutical companies will use ... to treat various neurological diseases. Orasi is currently in ...
... Side discrepancy errors in radiology reports do occur and ... communicate well to help prevent errors in clinical management, ... Boston, MA. "Side discrepancy errors refer to instances when ... one or more sections of the radiology report," said ...
... Hard to Treat Diseases, Inc. (HTDS:PK) http://www.htdsmedical.com reports ... of some significant new advances recently announced regarding the ... are currently conducting research. , On Wednesday, May 13, ... A ground-breaking Canada-wide clinical ...
... St. Cloud Orthopedic Associates (SCOA), the largest orthopedic physician ... chosen to partner with the St. Cloud Surgical Center, ... a group of local physicians. SCA is a leading ... allow St. Cloud Surgical Center, which has provided high ...
Cached Medicine News:Health News:TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 2Health News:TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 3Health News:TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital 4Health News:Glucose Control Pays Long-Term Benefits for Diabetics 2Health News:Hard to Treat Diseases, Inc. (HTDS) Reports on New Uses For Ribavirin 2Health News:Hard to Treat Diseases, Inc. (HTDS) Reports on New Uses For Ribavirin 3Health News:St. Cloud Orthopedic Associates to Partner with Surgical Care Affiliates 2
... Used retrograde to ... establish a Peel-Away ureteral ... The temporary protective Peel-Away ... away as the ureteroscope ...
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
... design allows the ureter to be dilated ... at the base of the balloon allows ... dilation. Supplied sterile in peel-open packages. Intended ... Handle (plastic), Straight Safety Wire Guide [.038 ...
... Fr Straight Channel; 33 or 42 cm ... Operating Ureteroscopes offer a small distal diameter ... to the ureter for diagnosis and treatment. ... ideal for large operating instruments, mechanical (Lithoclast) ...
Medicine Products: